日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies

间变性淋巴瘤激酶 (ALK) 抑制剂可增强 CD47 阻断诱导的对 ALK 敏感和耐药的恶性肿瘤的吞噬作用

Malighetti, Federica; Villa, Matteo; Mauri, Mario; Piane, Simone; Crippa, Valentina; Crespiatico, Ilaria; Cocito, Federica; Bossi, Elisa; Steidl, Carolina; Civettini, Ivan; Scollo, Chiara; Ramazzotti, Daniele; Gambacorti-Passerini, Carlo; Piazza, Rocco; Mologni, Luca; Aroldi, Andrea

Idiopathic erythrocytosis: a germline disease?

特发性红细胞增多症:一种生殖细胞疾病?

Elli, E M; Mauri, M; D'Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R

Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients

通过对超过35000名患者的基因组分析,揭示了人类癌症的进化特征

Fontana, Diletta; Crespiatico, Ilaria; Crippa, Valentina; Malighetti, Federica; Villa, Matteo; Angaroni, Fabrizio; De Sano, Luca; Aroldi, Andrea; Antoniotti, Marco; Caravagna, Giulio; Piazza, Rocco; Graudenzi, Alex; Mologni, Luca; Ramazzotti, Daniele

Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples

对超过150万份原始测序样本中的SARS-CoV-2突变特征进行表征

Aroldi, Andrea; Angaroni, Fabrizio; D'Aliberti, Deborah; Spinelli, Silvia; Crespiatico, Ilaria; Crippa, Valentina; Piazza, Rocco; Graudenzi, Alex; Ramazzotti, Daniele

Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma

协同药物组合可预防 ALK+ 间变性大细胞淋巴瘤产生耐药性

Giulia Arosio, Geeta G Sharma, Matteo Villa, Mario Mauri, Ilaria Crespiatico, Diletta Fontana, Chiara Manfroni, Cristina Mastini, Marina Zappa, Vera Magistroni, Monica Ceccon, Sara Redaelli, Luca Massimino, Anna Garbin, Federica Lovisa, Lara Mussolin, Rocco Piazza, Carlo Gambacorti-Passerini, Luca M

ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine

ETNK1 突变会诱发一种可通过磷酸乙醇胺逆转的突变表型

Diletta Fontana, Mario Mauri, Rossella Renso, Mattia Docci, Ilaria Crespiatico, Lisa M Røst, Mi Jang, Antonio Niro, Deborah D'Aliberti, Luca Massimino, Mayla Bertagna, Giovanni Zambrotta, Mario Bossi, Stefania Citterio, Barbara Crescenzi, Francesca Fanelli, Valeria Cassina, Roberta Corti, Domenico S

An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.

一例对伊马替尼无反应且携带 ABL Leu387Trp 突变的患者在接受博舒替尼治疗后获得细胞遗传学和分子学缓解:病例报告和生物学特征分析

Crespiatico Ilaria, Bossi Elisa, Brioschi Filippo, Piazza Rocco, Mologni Luca, Gambacorti-Passerini Carlo

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

在慢性粒细胞白血病进展过程中,UBE2A 新发突变会反复发生,并干扰髓系分化途径

Vera Magistroni, Mario Mauri, Deborah D'Aliberti, Caterina Mezzatesta, Ilaria Crespiatico, Miriam Nava, Diletta Fontana, Nitesh Sharma, Wendy Parker, Andreas Schreiber, David Yeung, Alessandra Pirola, Sara Readelli, Luca Massimino, Paul Wang, Praveen Khandelwal, Stefania Citterio, Michela Viltadi, S

A Microsphere-Based Suspension Array for Blood Group Molecular Typing: An Update

用于血型分子分型的微球悬浮阵列:最新进展

Drago, Francesca; Karpasitou, Katerina; Spinardi, Laura; Crespiatico, Loretta; Scalamogna, Mario; Poli, Francesca